Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study.

MLA

van Barele, Mark, et al. “Survival of BRCA1/BRCA2-Associated PT1 Breast Cancer Patients, a Cohort Study.” Breast Cancer Research and Treatment, vol. 194, no. 1, July 2022, pp. 159–70. EBSCOhost, https://doi.org/10.1007/s10549-022-06608-1.

APA

van Barele, M., Rieborn, A., Heemskerk-Gerritsen, B. A. M., Obdeijn, I.-M., Koppert, L. B., Loo, C. E., Tollenaar, R. A. E. M., Ausems, M. G. E. M., van de Beek, I., Berger, L. P. V., de Boer, M., van Hest, L. P., Kets, C. M., Rookus, M., Schmidt, M. K., Jager, A., & Hooning, M. J. (2022). Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study. Breast Cancer Research and Treatment, 194(1), 159–170. https://doi.org/10.1007/s10549-022-06608-1

Chicago

van Barele, Mark, Amy Rieborn, Bernadette A M Heemskerk-Gerritsen, Inge-Marie Obdeijn, Linetta B Koppert, Claudette E Loo, Rob A E M Tollenaar, et al. 2022. “Survival of BRCA1/BRCA2-Associated PT1 Breast Cancer Patients, a Cohort Study.” Breast Cancer Research and Treatment 194 (1): 159–70. doi:10.1007/s10549-022-06608-1.